CB Insights
Technology Market Intelligence
Technology Market Intelligence
MiroBio develops antibodies and variants to stimulate specific immune cell signals, allowing it to harness the natural control mechanisms of the immune system for therapeutic benefit across a range of diseases.
Company (Alive / Active)
Phone: 01865 618817
BioEscalator
Roosevelt Drive
Oxford, OX3 7FZ
England, United Kingdom
| Total Funding | Date of Last Funding | |
|---|---|---|
| MiroBio | $33.3M | Oct 7, 2019 |
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Company | Status | Description | Investors |
|---|---|---|---|
| Arlington, Massachusetts, United States | Alive / Active | TetraGenetics is an entrepreneurial biotech company focused on the discovery of therapeutics for autoimmune disease and pain. The company specializes in recombinant human ion channel protein production using its proprietary TetraExpress system. The company uses proteins as antigens in antibody discovery programs using a wide variety of animal systems. Its purified proteins are also used for structure determination supporting rational design of small molecule drugs. | Login to see details |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|
